ATE309811T1 - Analgetikum aus schlangengift - Google Patents

Analgetikum aus schlangengift

Info

Publication number
ATE309811T1
ATE309811T1 AT99900282T AT99900282T ATE309811T1 AT E309811 T1 ATE309811 T1 AT E309811T1 AT 99900282 T AT99900282 T AT 99900282T AT 99900282 T AT99900282 T AT 99900282T AT E309811 T1 ATE309811 T1 AT E309811T1
Authority
AT
Austria
Prior art keywords
analgesic
fraction
snake venom
toxic
venom
Prior art date
Application number
AT99900282T
Other languages
English (en)
Inventor
Aharon Di Shulov
Naftali Primor
Original Assignee
S I S Shulov Inst For Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I S Shulov Inst For Science filed Critical S I S Shulov Inst For Science
Application granted granted Critical
Publication of ATE309811T1 publication Critical patent/ATE309811T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/856Snakes; venom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/858Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99900282T 1998-01-20 1999-01-13 Analgetikum aus schlangengift ATE309811T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12300198A IL123001A (en) 1998-01-20 1998-01-20 Analgesic fraction from snake March and pharmacy preparations containing it
PCT/IL1999/000020 WO1999036078A1 (en) 1998-01-20 1999-01-13 Analgesic from snake venom

Publications (1)

Publication Number Publication Date
ATE309811T1 true ATE309811T1 (de) 2005-12-15

Family

ID=11071113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900282T ATE309811T1 (de) 1998-01-20 1999-01-13 Analgetikum aus schlangengift

Country Status (9)

Country Link
US (1) US6555109B1 (de)
EP (1) EP1049479B1 (de)
JP (1) JP2002509110A (de)
AT (1) ATE309811T1 (de)
AU (1) AU754119B2 (de)
CA (1) CA2318279A1 (de)
DE (1) DE69928375T2 (de)
IL (1) IL123001A (de)
WO (1) WO1999036078A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767940B2 (en) * 1999-07-14 2003-11-27 S.I.S Shulov Institute For Science Ltd. Analgesic from snake venom
RU2157694C1 (ru) * 1999-12-16 2000-10-20 Дубинина Лариса Васильевна Аэрозольный репаративно-регенеративный препарат, способ его изготовления и лечебного использования
SE0003619L (sv) * 1999-12-28 2001-08-23 Bjoern Oertenheim Farmaceutisk komposition och metod för dess framställning
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
RU2261719C2 (ru) * 2000-10-27 2005-10-10 Писарев Александр Геннадьевич Водно-спиртовая настойка
EP1765851B1 (de) * 2004-05-06 2011-11-16 Laboratório Biosintética Ltda. Analoge Verbindungen analgetischer Peptide, abgeleitet vom Crotalus durissus terrificus Schlangengift, ihre Verwendungen, Zusammensetzungen und Verfahren ihrer Herstellung und Reinigung
US20060034823A1 (en) * 2004-08-13 2006-02-16 Paul Reid Method of production and use of crotoxin as an analgesic
DE602005027582D1 (de) * 2004-08-16 2011-06-01 Medical Res Fund Of Tel Aviv Sourasky Medical Ct Verfahren und zusammensetzung zur modulation des systemischen entzündlichen reaktionssyndroms (sirs)
US20060234934A1 (en) * 2005-04-15 2006-10-19 Kilmon Joseph A Composition and Method for Selective Cytostasis
US7444605B2 (en) * 2005-10-06 2008-10-28 Synopsys, Inc. Generating a base curve database to reduce storage cost
US20070148159A1 (en) * 2005-12-22 2007-06-28 Reid Paul F Use of crotoxin as an analgesic - CIP
ES2598829T3 (es) 2011-03-28 2017-01-30 S.I.S. Shulov Innovative Science Ltd. Procedimiento de tratamiento de trastornos cutáneos
WO2016145256A1 (en) * 2015-03-10 2016-09-15 Reid Paul F Use of components of cobra venom for treatment of chronic kidney disease
KR102340534B1 (ko) * 2019-07-02 2021-12-21 독립바이오제약(주) Naja melanoleuca로부터 유래된 뱀독을 포함하는 류마티스 관절염의 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU435824A1 (de) 1972-08-15 1974-07-15 Н. Б. Шоттер, А. Я. Синка, О. Л. вээ , А. Ф. Раков Тал инский химико фармацевтический завод
FR2578745B1 (fr) * 1985-03-18 1989-05-12 Berdal Pascal Preparations pharmaceutiques fluidifiant le sang
US5164196A (en) * 1987-05-19 1992-11-17 Ventech Research, Inc. Crotoxin complex as cytotoxic agent
WO1991001740A1 (en) 1989-08-05 1991-02-21 Varánusz Gm Process for producing pharmacosmetics
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms

Also Published As

Publication number Publication date
WO1999036078A1 (en) 1999-07-22
IL123001A (en) 1998-12-06
DE69928375D1 (de) 2005-12-22
AU1888799A (en) 1999-08-02
US6555109B1 (en) 2003-04-29
JP2002509110A (ja) 2002-03-26
CA2318279A1 (en) 1999-07-22
EP1049479B1 (de) 2005-11-16
DE69928375T2 (de) 2006-08-10
AU754119B2 (en) 2002-11-07
IL123001A0 (en) 1998-08-16
EP1049479A4 (de) 2003-04-09
EP1049479A1 (de) 2000-11-08

Similar Documents

Publication Publication Date Title
ATE309811T1 (de) Analgetikum aus schlangengift
TW200510375A (en) New compounds
EP1007556A4 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
AU2002360488A1 (en) Methods and devices for detection and therapy of atheromatous plaque
BR9915744A (pt) Derivados 4-arilquinolin-2-ona 3-substituìdos como moduladores do canal de potássio
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
EA199900448A1 (ru) Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos
NO306779B1 (no) Naftalamider, anvendelse derav og farmasöytisk preparat
ES2192839T3 (es) Timosina beta 4 oxidada.
NO20030724D0 (no) Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
NO985342D0 (no) Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
NO20041166L (no) Anvendelse av optisk rent (+) norcisaprid sammen med et annet terapeutisk middel for fremstilling av et medikament
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
SE9802208D0 (sv) Novel compounds
NO991619L (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
NO983530D0 (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
AU9678501A (en) Pharmaceutical solutions of modafinil compounds
ATE249835T1 (de) Immunoregulator
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
EA199800866A1 (ru) Способ снятия боли
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
HK1049439A1 (zh) 從蛇毒中得到的止痛劑

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties